BioMarin Pharmaceutical, Inc. (BMRN)
62.92
-1.16
(-1.81%)
USD |
NASDAQ |
Feb 23, 16:00
61.42
-1.50
(-2.38%)
After-Hours: 19:59
BioMarin Pharmaceutical EPS Diluted (Quarterly) : -0.1601 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0054 |
| Gilead Sciences, Inc. | 1.74 |
| Merck & Co., Inc. | 1.191 |
| AbbVie, Inc. | 1.018 |
| Bristol Myers Squibb Co. | 0.5326 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.74M |
| Revenue (Quarterly) | 786.77M |
| Total Expenses (Quarterly) | 817.52M |
| Enterprise Value | 11.22B |
| Gross Profit Margin (Quarterly) | 81.58% |
| Profit Margin (Quarterly) | -3.91% |
| Earnings Yield | 4.24% |
| Operating Earnings Yield | 6.95% |
| Normalized Earnings Yield | 5.672 |